![Adam Willis Perriman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adam Willis Perriman active positions
Companies | Position | Start | End |
---|---|---|---|
Cytoseek Ltd.
![]() Cytoseek Ltd. Miscellaneous Commercial ServicesCommercial Services Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom. | Director/Board Member | 22/11/2017 | - |
Founder | 22/11/2017 | - |
Career history of Adam Willis Perriman
Statistics
International
United Kingdom | 2 |
Operational
Director/Board Member | 1 |
Founder | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Cytoseek Ltd.
![]() Cytoseek Ltd. Miscellaneous Commercial ServicesCommercial Services Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Adam Willis Perriman
- Experience